Imaging a pancreatic carcinoma xenograft model with 11C-acetate: A comparison study with 18F-FDG

Nuclear Medicine Communications

Volumn 30, Issue 12, 2009, Pages 971-977

  Zhao, Chunlei ^a,b,c   Chen, Zhanhong ^d   Ye, Xiaojuan ^a,b,c   Zhang, Ying ^a,b,c   Zhan, Hongwei ^a,b,c   Aburano, Tamio ^e   Tian, Mei ^f   Zhang, Hong ^a,b,c  

^a THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Key Laboratory of Medical Molecular Imaging of Zhejiang Province   (China)

^d ZHEJIANG CANCER HOSPITAL   (China)

^e ASAHIKAWA MEDICAL COLLEGE   (Japan)

^f UNIVERSITY OF TEXAS   (United States)

Author keywords

11C acetale; 18F FDG; Pancreatic carcinoma; PET

Indexed keywords

ACETIC ACID C 11; CYCLINE; FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; TUMOR XENOGRAFT;

ACETATES; ADENOCARCINOMA; ANIMALS; CARBON; CARBON RADIOISOTOPES; CELL LINE, TUMOR; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; MALE; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROLIFERATING CELL NUCLEAR ANTIGEN; RADIOPHARMACEUTICALS;

EID: 73649120299     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328330adfc     Document Type: Article

References (27)

1. Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter DW, Moossa AR. Factors influencing survival after resection for periampullary neoplasms. Am J Surg 2000; 180:13-17.
2. Nakagohri T, Kinoshita T, Konishi M, Inoue K, Takahashi S. Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 2003; 186:149-153.
3. Kobari M, Matsuno S. Staging systems for pancreatic cancer: differences between the Japanese and UICC systems. J Hepatobiliary Pancreat Surg 1998; 5:121-127.
4. Bouvet M, Binmoeller KF, Moossa AR. Diagnosis of adenocarcinoma of the pancreas. In: Cameron JL, editor. American Cancer Society Atlas of Clinical Oncology. Pancreatic cancer. Hamilton, Ontario, Canada: BC Decker; 2001. pp. 67-86.
5. Miura F, Takada T, Amano H, Yoshida M, Furui S, Takeshita K. Diagnosis of pancreatic cancer. HPB (Oxford) 2006; 8:337-342. (Pubitemid 44473457)
6. Van Kouwen MC, Oyen WJ, Nagengast FM, Jansen JB, Drenth JP. FDG-PET scanning in the diagnosis of gastrointestinal cancers. Scand J Gastroenterol Suppl 2004; 241:85-92.
7. Hustinx R. PET imaging in assessing gastrointestinal tumors. Radiol Clin North Am 2004; 42:1123-1139. ix
8. Valinas R, Barrier A, Montravers F, Houry S, Talbot JN, Huguier M. [18F-fluorodeoxyglucose positron emission tomography for characterization and initial staging of pancreatic tumors]. Gastroenterol Clin Biol 2002; 26:888-892.
9. Mansour JC, Schwartz L, Pandit-Taskar N, D'Angelica M, Fong Y, Larson SM, et al. The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas. J Gastrointest Surg 2006; 10:1354-1360.
10. Rasmussen I, Sorensen J, Langstrom B, Haglund U. Is positron emission tomography using 18F-fluorodeoxyglucose and 11C-acetate valuable in diagnosing indeterminate pancreatic masses? Scand J Surg 2004; 93:191-197.
11. Choi Y, Huang SC, Hawkins RA, Hoh CK, Krivokapich J, Buxton DB, et al. A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. J Nucl Med 1993; 34:2038-2043.
12. Chen S, Ho C, Feng D, Chi Z. Tracer kinetic modeling of 11C-acetate applied in the liver with positron emission tomography. IEEE Trans Med Imaging 2004; 23:426-432.
13. Dimitrakopoulou-Strauss A, Strauss LG. PET imaging of prostate cancer with 11C-acetate. J Nucl Med 2003; 44:556-558.
14. Kaji M, Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. 11C-acetate and 18F-fluorodeoxyglucose positron emission tomography of pulmonary adenocarcinoma. Ann Thorac Surg 2007; 83:312-314.
15. Sun A, Sorensen J, Karlsson M, Turesson I, Langstrom B, Nilsson P, et al. 1-[11C]-acetate PET imaging in head and neck cancer - a comparison with 18F-FDG-PET: implications for staging and radiotherapy planning. Eur J Nucl Med Mol Imaging 2007; 34:651-657.
16. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T,Wu H, Burger C, Bernd L, Ewerbeck V. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med 2002; 43:510-518.
17. Brudin LH, Valind SO, Rhodes CG, Pantin CF, Sweatman M, Jones T, Hughes JM. Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography. Eur J Nucl Med 1994; 21:297-305.
18. Bleeker-Rovers CP, Vos FJ, Corstens FH, Oyen WJ. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging 2008; 52:17-29.
19. Horiuchi C, Tsukuda M, Taguchi T, Ishiguro Y, Okudera K, Inoue T. Correlation between FDG-PET findings and GLUT1 expression in salivary gland pleomorphic adenomas. Ann Nucl Med 2008; 22:693-698.
20. Inoue M, Tajima K, Takezaki T, Hamajima N, Hirose K, Ito H, Tominaga S. Epidemiology of pancreatic cancer in Japan: a nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol 2003; 32:257-262.
21. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001; 28:117-122.
22. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326:515-517.
23. Theunissen PH, Leers MP, Bollen EC. Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small cell lung carcinoma. Histopathology 1992; 20:251-255.
24. Liang CY, Liu X, Zhang JM, Zhou NK, Zhang T, Liu HF. [Biodistribution and positron emission tomography imaging of 11C-acetate in murine model of lung carcinoma]. Zhonghua Yi Xue Za Zhi 2008; 88:778-780.
25. Ponde DE, Dence CS, Oyama N, Kim J, Tai YC, Laforest R, et al. 18F-fluoroacetate: a potential acetate analog for prostate tumor imaging - in vivo evaluation of 18F-fluoroacetate versus 11C-acetate. J Nucl Med 2007; 48:420-428.
26. Shreve PD, Gross MD. Imaging of the pancreas and related diseases with PET carbon-11-acetate. J Nucl Med 1997; 38:1305-1310.
27. Nomori H, Kosaka N,Watanabe K, Ohtsuka T, Naruke T, Kobayashi T, et al. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography. Ann Thorac Surg 2005; 80:2020-2025.